Local inflammation exacerbates the severity of Staphylococcus aureus skin infection

scientific article

Local inflammation exacerbates the severity of Staphylococcus aureus skin infection is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2013PLoSO...869508M
P356DOI10.1371/JOURNAL.PONE.0069508
P932PMC publication ID3702601
P698PubMed publication ID23861974
P5875ResearchGate publication ID249967849

P50authorRobert S DaumQ106083100
P2093author name stringFan Zhao
Brad Spellberg
Christopher P Montgomery
Anita S Chong
Melvin D Daniels
P2860cites workCommunity-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicQ24614464
Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndromeQ29614595
Invasive methicillin-resistant Staphylococcus aureus infections in the United StatesQ29616087
Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSAQ29617470
Genetic, biochemical, and clinical features of chronic granulomatous disease.Q30168989
SaeR binds a consensus sequence within virulence gene promoters to advance USA300 pathogenesisQ33557004
Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infectionQ33769704
IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in miceQ33815790
The nude mouse: a model of deficient T-cell functionQ34069957
Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis.Q34931778
Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infectionQ35167140
The damage-response framework of microbial pathogenesisQ35709086
Genetic requirement for ADAM10 in severe Staphylococcus aureus skin infectionQ35888551
Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosisQ36457770
The future of antibiotics and resistanceQ36741884
The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureusQ36898452
The arginine catabolic mobile element is not associated with enhanced virulence in experimental invasive disease caused by the community-associated methicillin-resistant Staphylococcus aureus USA300 genetic backgroundQ37256515
Resistance of athymic nude mice to experimental cutaneous Bacillus anthracis infectionQ37471165
Methicillin-resistant Staphylococcus aureus (MRSA) infections among HIV-infected persons in the era of highly active antiretroviral therapy: a review of the literatureQ37978658
Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureusQ39516734
Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses.Q44894318
Methicillin-ResistantS. aureusInfections among Patients in the Emergency DepartmentQ55897489
Abnormal distribution of T cell subsets in athymic miceQ68798780
Intestinal gamma delta T cells develop in mice lacking thymus, all lymph nodes, Peyer's patches, and isolated lymphoid folliclesQ81377825
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectStaphylococcus aureusQ188121
inflammationQ101991
P304page(s)e69508
P577publication date2013-07-05
P1433published inPLOS OneQ564954
P1476titleLocal inflammation exacerbates the severity of Staphylococcus aureus skin infection
P478volume8

Reverse relations

cites work (P2860)
Q34922452Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model.
Q36212803Antibacterial activity and therapeutic efficacy of Fl-P(R)P(R)P(L)-5, a cationic amphiphilic polyproline helix, in a mouse model of staphylococcal skin infection.
Q52592947Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds.
Q38524810Cutaneous Immune Defenses Against Staphylococcus aureus Infections
Q37023281Efficacy of Lantibiotic Treatment of Staphylococcus aureus-Induced Skin Infections, Monitored by In Vivo Bioluminescent Imaging
Q34394175Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection
Q40304301Eradication and Sensitization of Methicillin Resistant Staphylococcus aureus to Methicillin with Bioactive Extracts of Berry Pomace.
Q37089144Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus
Q36265781Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent
Q36735408Importance of B Lymphocytes and the IgG-Binding Protein Sbi in Staphylococcus aureus Skin Infection
Q47340403Innate Sex Bias of Staphylococcus aureus Skin Infection Is Driven by α-Hemolysin.
Q40235599Nanoemulsion is an effective antimicrobial for methicillin-resistant Staphylococcus aureus in infected wounds
Q36689702Repurposing auranofin for the treatment of cutaneous staphylococcal infections
Q35895183Repurposing celecoxib as a topical antimicrobial agent.
Q35783692Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections
Q38998331Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides.
Q36242810The TIR Homologue Lies near Resistance Genes in Staphylococcus aureus, Coupling Modulation of Virulence and Antimicrobial Susceptibility
Q35730332Tissue-specific patterning of host innate immune responses by Staphylococcus aureus α-toxin
Q89494836Topical Therapeutic Efficacy of Ebselen Against Multidrug-Resistant Staphylococcus aureus LT-1 Targeting Thioredoxin Reductase

Search more.